Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Jeannine
    Member
    • Sep 2009
    • 14

    #1

    Only 2% mapped reads?????

    Hey there,

    I'm currently doing basic analysis for 3 different ChIP-seq experiments, i.e.mapping (using BWA) and peak calling (MACS). All 3 samples have been processed at the same time, give approx.38million reads each (131bp reads) and the sequence quality is the same (not extremely good but alright after trimming).
    BUT, when I mapped the reads to the genome (b37), only 2% of the reads of one sample map, while I get approx.85% mapped reads with the other two samples. 2 % ???!!
    How can that happen? Any suggestions what went wrong or where the problem is? Just by looking at the sequence reads in the fastq file I can't see any problems... Any help highly appreciated!!!!
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    First thing I always do when a library seems to fail that badly is blast some of the reads to make sure they actually match the organism. I have identified many problems with libraries before using this approach.

    Comment

    • gringer
      David Eccles (gringer)
      • May 2011
      • 845

      #3
      I've had a yeast sample contaminated with human samples which fitted this pattern. I got back something like 1-2% of reads mapping to yeast mRNA, and eventually discovered (after a few days of frustration) that around 70% of the reads mapped to the human genome.

      Now for mRNA reads I map to the SILVA rRNA database as something of a quality check, then give people stories about the probability of human rRNA contamination (e.g. if you accept that there was human contamination, then you also need to accept contamination from a lobster, a NZ weta, and a small bat).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Working...